Tu1647 HUMORAL IMMUNOGENICITY TO MRNA COVID-19 VACCINES AMONG PATIENTS WITH ULCERATIVE COLITIS TREATED WITH OZANIMOD

Freddy Caldera; Aditi Basu Bal; Ruifeng Hu; John Schwarz; Yi Luo; Jiangwei Zhang; Sarah Harris

doi:10.1016/s0016-5085(26)03334-2

Related publications

Article2026

Tu1647 HUMORAL IMMUNOGENICITY TO MRNA COVID-19 VACCINES AMONG PATIENTS WITH ULCERATIVE COLITIS TREATED WITH OZANIMOD

Freddy Caldera, Aditi Basu Bal, Ruifeng Hu, John Schwarz, Yi Luo, Jiangwei Zhang, Sarah Harris

Article2022

Immunogenicity of COVID‐19 vaccines in patients with diverse health conditions: A comprehensive systematic review

Kyuyeon Cho, Seoyeon Park, Eun Young Kim, Ai Koyanagi, Louis Jacob, Dong Keon Yon, Seung Won Lee, Min Seo Kim, Joaquim Raduà, Dragioti Elena, Jae Il Shin, Lee Smith

Article2022

Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis

Ioannis P. Trougakos, Evangelos Terpos, Harry Alexopoulos, Marianna Politou, Dimitrios Paraskevis, Andreas Scorilas, Efstathios Kastritis, Evangelos Andreakos, Meletios A Dimopoulos

Article2021

Comparative safety of mRNA COVID‐19 vaccines to influenza vaccines: A pharmacovigilance analysis using WHO international database

Min Seo Kim, Se Yong Jung, Jong Gyun Ahn, Se-Jin Park, Yehuda Shoenfeld, Andreas Kronbichler, Ai Koyanagi, Elena Dragioti, Kalthoum Tizaoui, Sung Hwi Hong, Louis Jacob, Joe‐Elie Salem, Dong Keon Yon, Seung Won Lee, Shuji Ogino, Hanna Kim, Jerome H. Kim, Jean‐Louis Excler, Florian Marks, J. D. Clemens, Michael Eisenhut, Yvonne Barnett, Laurie T. Butler, Cristian Ilie,

Article2021

Role of nanotechnology behind the success of mRNA vaccines for COVID-19

Amit Khurana, Prince Allawadhi, Isha Khurana, Sachin Allwadhi, Ralf Weiskirchen, Anil Kumar Banothu, Deepak Chhabra, Kamaldeep Joshi, Kala Kumar Bharani

Tu1647 HUMORAL IMMUNOGENICITY TO MRNA COVID-19 VACCINES AMONG PATIENTS WITH ULCERATIVE COLITIS TREATED WITH OZANIMOD

Discussion(0)

Related publications

Tu1647 HUMORAL IMMUNOGENICITY TO MRNA COVID-19 VACCINES AMONG PATIENTS WITH ULCERATIVE COLITIS TREATED WITH OZANIMOD

Immunogenicity of COVID‐19 vaccines in patients with diverse health conditions: A comprehensive systematic review

Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis

Comparative safety of mRNA COVID‐19 vaccines to influenza vaccines: A pharmacovigilance analysis using WHO international database

Role of nanotechnology behind the success of mRNA vaccines for COVID-19